Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
Sonya Heltshe
Study ID
NCT04509050
Status
Recruiting

Conditions

  • Cystic Fibrosis

Eligibility Criteria

Sex
ALL
Age
N/A - 10 Years
Healthy Volunteers
Not accepted

Interventions

  • Ivacaftor or elexacaftor/tezacaftor/ivacaftor — DRUG
    In Part B, approved CFTR modulator as prescribed at the discretion of the treating physician -not dictated by the BEGIN investigators

Study Details

This is a two-part, multi-center, prospective longitudinal, exploratory study of highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulators and their impact on children with cystic fibrosis (CF).

Key Dates

Start date
Nov 18, 2020
Status verified
Aug 2024
Primary completion
Dec 1, 2029
Completion
Dec 1, 2029

Study Design

Enrollment
210 participants (estimated)

Arms

  • Arm: Part A
    Children with CF not on ivacaftor or elexacaftor/tezacaftor/ivacaftor CFTR modulator therapy.
  • Arm: Part B
    Children with CF planning to start ivacaftor or elexacaftor/tezacaftor/ivacaftor CFTR modulator therapy. Participants from the Part A cohort of this study may enroll into the Part B cohort if they become eligible for these CFTR modulator therapies and plan to start them.

Primary Outcome Measure

Part A Primary Outcome Measure: Change in weight-for-age z-scores [ Time Frame: Baseline to 12 months ]

Central Contacts

Locations (35)

FacilityCityStateZIPSite coordinators
The Children's Hospital Alabama, University of Alabama at BirminghamBirminghamAlabama35233
Heather Hathorne
Stanford University Medical CenterPalo AltoCalifornia94304
Jacquelyn Spano
Children's Hospital ColoradoAuroraColorado80045
Nemours Children's ClinicJacksonvilleFlorida32207
Jennifer (Jenn) Gafford
University of MiamiMiamiFlorida33136
Ylber (Ivan) Whitaker
The Nemours Children's Clinic - OrlandoOrlandoFlorida32827
Sherry Wooldridge
Riley Hospital for ChildrenIndianapolisIndiana46202
University of IowaIowa CityIowa52242
University of Kansas Medical CenterKansas CityKansas66160
Lawrence Scott
Boston Children's HospitalBostonMassachusetts02115
Robert Fowler
University of Michigan, Michigan MedicineAnn ArborMichigan48109
Helen DeVos Children's HospitalGrand RapidsMichigan49503
Andrew James
Children's Hospitals and Clinics of MinnesotaMinneapolisMinnesota55404
Camerone Bey
The Minnesota Cystic Fibrosis CenterMinneapolisMinnesota55455
CF Trials Contact
Children's Mercy Kansas CityKansas CityMissouri64108
Candy Schmoll
St. Louis Children's HospitalSt LouisMissouri63110
The Cystic Fibrosis Center of Western New YorkBuffaloNew York14203
Christine Roach
Children's Hospital of New YorkNew YorkNew York10032
Hossein Sadeghi
SUNY Upstate Medical UniversitySyracuseNew York13210
New York Medical College at Westchester Medical CenterValhallaNew York10595
Zachary Messer
Cincinnati Children's Hospital Medical CenterCincinnatiOhio45229
Kelly Thornton
Nationwide Children's HospitalColumbusOhio43205
Diana Gilmore
Oklahoma Cystic Fibrosis CenterOklahoma CityOklahoma73104
CF Center Participant Contact
Oregon Health Sciences UniversityPortlandOregon97239
Jenna Bucher
Hershey Medical Center Pennsylvania State UniversityHersheyPennsylvania17033
Diane M Kitch
Children's Hospital of PhiladelphiaPhiladelphiaPennsylvania19104
Erin Donnelly
Children's Hospital of Pittsburgh of UPMCPittsburghPennsylvania15224
Elizabeth Hartigan
University of Texas Southwestern / Children's HealthDallasTexas75207
Keianna Brown
Cook Children's Medical CenterFort WorthTexas76104
Baylor College of MedicineHoustonTexas77030
Tracy Mosely
Primary Children's Cystic Fibrosis CenterSalt Lake CityUtah84113
Jane B Vroom
Vermont Children's HospitalBurlingtonVermont05401
University of VirginiaCharlottesvilleVirginia22903
Erica Tharrington
Seattle Children's HospitalSeattleWashington98105
Sharon McNamara
University of WisconsinMadisonWisconsin53792
Melanie Nelson

Find similar trials in Birmingham, AL

Related Studies